USPTO serial 97797313
GLYCOLOCATE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DEAN, JULES J.
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GLYCOLOCATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boston, MA, US
Boston, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua S. Jarvis
Joshua S. Jarvis FOLEY HOAG LLP155 SEAPORT BLVD.BOSTON, MA 02210-2600United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic downloadable publications, namely, articles and reports in the fields of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases | ACTIVE | — |
| 010 | Diagnostic apparatus for the early detection of cancer, other cellular and tissue-based and diseases and disorders, and other diseases; medical diagnostic apparatus for detecting cancer, other cellular and tissue-based and diseases and disorders, and other diseases; medical diagnostic apparatus for testing for cancer, other cellular and tissue-based and diseases and disorders, and other diseases; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing | ACTIVE | — |
| 035 | Providing consumer product information relating to diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based and diseases and disorders, and other diseases | ACTIVE | — |
| 041 | Providing a website featuring blogs and non-downloadable publications in the nature of articles and reports in the fields of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases | ACTIVE | — |
| 042 | Scientific research and development; product research and development; research and development in the fields of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; consulting services in the field of research and development of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing information in the field of research and development of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing medical and scientific research information in the field of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing temporary use of non-downloadable software for physicians and healthcare providers to input and upload clinical and diagnostic data and to receive information, analyses, and reports in the field of diagnostics related to cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing a website featuring technology that allows physicians and healthcare providers to input and upload clinical and diagnostic data and to receive information, analyses, and reports in the field of diagnostics related to cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases | ACTIVE | — |
| 044 | Providing medical information; providing medical information in the field of diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; medical consultations; medical consultations in the field of diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AOA Dx Inc.
- Other trademarks owned by AOA Dx Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GLYCOLOCATE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 14, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 3, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 3, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 15, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 15, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 15, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 10, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 12, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 12, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 12, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 13, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 16, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 15, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 6, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2023 | NWAP | NEW APPLICATION ENTERED | — |